Phase
Condition
Neuropathy
Polymyositis (Inflammatory Muscle Disease)
Treatment
efgartigimod
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients diagnosed with gMG who are expected to start commercial efgartigimod atenrolment or who are within their first cycle of efgartigimod at enrolment orPatients diagnosed with gMG who have not been exposed to efgartigimod and for whomit is not planned to start treatment with efgartigimod at enrolment
Have provided appropriate written informed consent
Exclusion
Exclusion Criteria:
- None
Study Design
Connect with a study center
UZ Leuven (University Hospitals Leuven)
Leuven, 3000
BelgiumActive - Recruiting
SFM Clinical Research, LLC
Boca Raton, Florida 33487
United StatesActive - Recruiting
BayCare Health System, Inc. St Anthony's Hospital
St. Petersburg, Florida 33705
United StatesActive - Recruiting
Prairie Education and Research Cooperative and HSHS Medical Group
O'Fallon, Illinois 62701
United StatesActive - Recruiting
Norton Neuroscience Institute
Louisville, Kentucky 40241
United StatesActive - Recruiting
National Neuromuscular Research Institute
Austin, Texas 78759
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.